Category: Biomarkers
North America Biomarkers
-
Small Animal Imaging Market Research Report Information by Product Optical Imaging (Photoacoustic Tomography and Optical Coherence Tomography), Nuclear Imaging (Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others), Reagent (Optical Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast to 2032
... Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the ... Read More
-
2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
... pages and 50 tables. The report presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cardiac biomarkers refer to proteins that are present in blood when the ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting neurological ... Read More
-
U.S. Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report By Type (Serum, Hepatic Fibrosis, Apoptosis), By End-use (Hospitals, Diagnostic Labs), And Segment Forecasts, 2024 - 2030
... Trends The U.S. non-alcoholic steatohepatitis biomarkers market size is anticipated to reach USD 2.84 billion by 2030 and is anticipated to expand at a CAGR of 23.9% from 2024 to 2030, according to a new ... Read More
-
North America Cardiac Markers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Kits, and Analyzers), Biomarker Type (Troponin, Creatine Kinase-MB, Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico)
... Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico) The global North ... Read More
-
2024 North America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Canada, Mexico - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com.This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and ... Read More
-
2024 Mexico Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends ... Read More
-
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research Centers), and Company Analysis 2024-2032
... Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research ... Read More
-
North America Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030
... North America Theranostics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030). The US market dominated the North America Theranostics Market by Country in 2022 and would continue to be a ... Read More
-
North America DNA Sequencing Products Market Report by Product Type (Consumables and Reagents, Equipment), Application (Biomarkers, Diagnostics, Reproductive Health, Forensics, Personalized Medicine, and Others), End-User (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Country 2024-2032
... and Clinics, and Others), and Country 2024-2032 The North America DNA sequencing products market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2032, ... Read More
-
North America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The North America bioanalytical testing services market was valued ... Read More
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
North America, Europe, and Asia-Pacific Large Molecule Bioanalysis Testing Services Market Research Report Forecast to 2030
... demand for high-tech and dependable large molecule bioanalytical testing services, a growing trend of outsourcing laboratory testing services, and an increase in the number of clinical trials. However, the difficulties in developing appropriate analytical techniques ... Read More
-
North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 ... Read More
-
NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
... to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031. Market Segmentation North America Acute Myeloid Leukemia ... Read More
-
Liquid Biopsy Market (4th Edition), 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates): Distribution by Application (Early Cancer Diagnosis, Patient Monitoring, Treatment Selection, Recurrence Monitoring and Others), Target Disease Indication (Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), End users (Hospitals, Research Institutes and Others), Stage of Development (Launched and Under Development), Type of Product (Assay kits, Devices, Software/ Algorithms and others), Type of Technique (Polymerase Chain Reaction, Next Generation Sequencing and Others), Application Area ( Clinical use, Research use only) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecast
... Gastric Cancer, Lung Cancer, Prostate Cancer and Others), Type of Circulating Biomarker (Cell Free DNA, Cell Free RNA, Circulating Tumor DNA, Extracellular Vesicles and Others Circulating Biomarkers), Type of Sample (Blood / Plasma and Others), ... Read More
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global breast tissue markers market witnessed revenue of $2.9 billion in 2024 and is poised to attain a market value of $6.1 billion by the end of 2031, as reported in a recent market ... Read More
-
Preterm Birth And Prom Testing Market, By Test Type (Pelvic exam, Ultrasound, Uterine monitoring, Biomarker testing, Others), By Product (PROM test kits, pH test kits, Ferning test kits, Ultrasound devices, Fetal fibronectin test kits, Others), By Method (Nitrazine test, Ferning test, Pooling, Ultrasound, Biomarker assays, Others), By End-User (Hospitals, Diagnostics laboratories, Outpatient clinics, Research centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Method (Nitrazine test, Ferning test, Pooling, Ultrasound, Biomarker assays, Others), By End-User (Hospitals, Diagnostics laboratories, Outpatient clinics, Research centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) ... Read More
-
Multiple Myeloma Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Smoldering (indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma); By Treatment (Chemotherapy, Targeted Therapy, Immunomodulatory Drugs, Steroids, Bone-Modifying Drugs, Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat Pad Aspirate, Biomarker Testing of the Tumor); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat ... Read More
-
2023-2027 U.S. Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global cancer biomarkers market is poised for significant growth and expansion in the upcoming years. Cancer biomarkers play a crucial role in early detection, diagnosis, and cancer monitoring applications by indicating the presence of cancer ... Read More
-
POCT Market in US 2023-2027
... market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
United States Prostate Cancer Testing Market By Biomarker Type (Pre-Biopsy/Post-Negative Biopsy Testing, Initial Evaluation: Prostate-Specific Antigen (Total PSA, Free PSA), Post-Biopsy Tissue Testing), By Application (Diagnostics Biomarkers, Prognostics Biomarkers), By End User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028
... Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028 United States Prostate Cancer Testing Market is expected to grow at an impressive rate during the forecast ... Read More
-
2023 Canada Tumor Markers Diagnostic Testing Market Assessment - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer ... Read More
Research Assistance
